- Home
- CKPT vs OFLX Comparison
CKPT vs OFLX Comparison
Compare CKPT & OFLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CKPT
- OFLX
- Stock Information
- Founded
- CKPT 2014
- OFLX 1975
- Country
- CKPT United States
- OFLX United States
- Employees
- CKPT N/A
- OFLX N/A
- Industry
- CKPT Biotechnology: Pharmaceutical Preparations
- OFLX Industrial Specialties
- Sector
- CKPT Health Care
- OFLX Industrials
- Exchange
- CKPT Nasdaq
- OFLX Nasdaq
- Market Cap
- CKPT 335.9M
- OFLX 374.3M
- IPO Year
- CKPT 2017
- OFLX 2005
- Fundamental
- Price
- CKPT $4.17
- OFLX $30.83
- Analyst Decision
- CKPT Buy
- OFLX
- Analyst Count
- CKPT 3
- OFLX 0
- Target Price
- CKPT $4.33
- OFLX N/A
- AVG Volume (30 Days)
- CKPT 1.0M
- OFLX 20.7K
- Earning Date
- CKPT 05-16-2025
- OFLX 04-30-2025
- Dividend Yield
- CKPT N/A
- OFLX 4.52%
- EPS Growth
- CKPT N/A
- OFLX N/A
- EPS
- CKPT N/A
- OFLX 1.72
- Revenue
- CKPT $41,000.00
- OFLX $99,795,000.00
- Revenue This Year
- CKPT $102,182.93
- OFLX N/A
- Revenue Next Year
- CKPT $351.71
- OFLX N/A
- P/E Ratio
- CKPT N/A
- OFLX $17.92
- Revenue Growth
- CKPT N/A
- OFLX N/A
- 52 Week Low
- CKPT $1.47
- OFLX $28.12
- 52 Week High
- CKPT $4.50
- OFLX $67.56
- Technical
- Relative Strength Index (RSI)
- CKPT 71.99
- OFLX 45.29
- Support Level
- CKPT $4.02
- OFLX $29.72
- Resistance Level
- CKPT $4.17
- OFLX $31.38
- Average True Range (ATR)
- CKPT 0.03
- OFLX 1.28
- MACD
- CKPT -0.01
- OFLX 0.30
- Stochastic Oscillator
- CKPT 93.33
- OFLX 68.61
About CKPT Checkpoint Therapeutics Inc.
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States.